Literature DB >> 5774078

Treatment of pulmonary embolism with streptokinase. A preliminary report.

G A Miller, R V Gibson, M Honey, G C Sutton.   

Abstract

Nine patients with arteriographically proved pulmonary embolism have been treated by a 36-hour infusion of streptokinase. Satisfactory haemodynamic and arteriographic resolution was obtained in four patients with acute massive pulmonary embolism and in two with recent minor embolism. Little or no haemodynamic or arteriographic improvement was obtained in three patients with pulmonary thromboembolic disease of longer duration.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5774078      PMCID: PMC1982486          DOI: 10.1136/bmj.1.5647.812

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  STREPTOKINASE AND PULMONARY EMBOLISM.

Authors:  N L BROWSE; D C JAMES
Journal:  Lancet       Date:  1964-11-14       Impact factor: 79.321

2.  Pulmonary embolism.

Authors:  P R ALLISON; M S DUNNILL; R MARSHALL
Journal:  Thorax       Date:  1960-12       Impact factor: 9.139

3.  Popliteal artery thrombosis treated with streptokinase.

Authors:  L T COTTON; P T FLUTE; M J TSAPOGAS
Journal:  Lancet       Date:  1962-11-24       Impact factor: 79.321

4.  Obliterative pulmonary hypertension and thrombo-embolism.

Authors:  J F GOODWIN; C V HARRISON; D E WILCKEN
Journal:  Br Med J       Date:  1963-03-16

5.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

6.  Resolution of acute massive pulmonary embolism after pulmonary arterial infusion of streptokinase.

Authors:  J Hirsh; G S Hale; I G McDonald; R A McCarthy; J F Cade
Journal:  Lancet       Date:  1967-09-16       Impact factor: 79.321

7.  Urokinase in pulmonary thromboembolic disease: a preliminary report.

Authors:  K Dickie; W de Groot
Journal:  Tex Rep Biol Med       Date:  1967

8.  Recovery of pulmonary arterial blood flow in patients with pulmonary embolism.

Authors:  D E Tow; H N Wagner
Journal:  N Engl J Med       Date:  1967-05-11       Impact factor: 91.245

9.  Rapid resolution of pulmonary thromboemboli in man. An angiographic study.

Authors:  H L Fred; M A Axelrad; J M Lewis; J K Alexander
Journal:  JAMA       Date:  1966-06-27       Impact factor: 56.272

10.  Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.

Authors:  J Hirsh; G S Hale; I G McDonald; R A McCarthy; A Pitt
Journal:  Br Med J       Date:  1968-12-21
View more
  11 in total

Review 1.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

2.  Treatment of acute massive pulmonary embolism by streptokinase during labour and delivery.

Authors:  R J Hall; C Young; G C Sutton; S Cambell
Journal:  Br Med J       Date:  1972-12-16

3.  Clinical experience with brinase.

Authors:  E P Frisch
Journal:  J Clin Pathol       Date:  1972-07       Impact factor: 3.411

4.  The treatment of pulmonary embolism.

Authors:  R L Hackney
Journal:  J Natl Med Assoc       Date:  1971-09       Impact factor: 1.798

5.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

6.  Cost of treatment.

Authors:  A J Jouhar
Journal:  Br Med J       Date:  1970-06-27

7.  Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism.

Authors:  G A Miller; G C Sutton; I H Kerr; R V Gibson; M Honey
Journal:  Br Med J       Date:  1971-06-19

Review 8.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  Resolution of pulmonary embolism.

Authors:  R H Walker; J Goodwin; J A Jackson
Journal:  Br Med J       Date:  1970-10-17

10.  Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

Authors:  J Hirsh; J F Cade; E Regoeczi; M Gent; M R Buchanan; D M Hynes
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.